Skip to main content
SpringerLink
Log in

Dinutuximab

Posterior reversible encephalopathy syndrome and hypertension: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Higgerson K, et al. Posterior resversible encephalopathy syndrome after dinutuximab. Pediatric Blood and Cancer 68 (Suppl.): S129, Jun 2021. Available from: URL: http://doi.org/10.1002/pbc.29060

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dinutuximab. Reactions Weekly 1856, 183 (2021). https://doi.org/10.1007/s40278-021-96176-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-96176-y

Search

Navigation